文献速递心脑血管急症重症综合管理与镇静镇痛

COVID-19大流行第一年住院患者SARS-CoV-2感染的神经系统表现

Neurologic Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospitalized Patients During the First Year of the COVID-19 Pandemic.
PubMed 文献 · Crit Care Explor · 2022-04-25
一句话结论住院COVID-19患者中12.9%出现严重神经系统表现,以入院时脑病最常见(10.2%),且与更严重疾病、更高ICU入住率和死亡率相关。

该前瞻性观察研究纳入24个国家179家医院、16225例实验室确诊SARS-CoV-2感染住院成人,描述严重神经系统表现(脑病、卒中、癫痫、脑膜炎/脑炎)的患病率、危险因素和结局。结果显示2092例(12.9%)出现严重神经系统表现,其中入院时脑病1656例(10.2%)、卒中331例(2.0%)、癫痫243例(1.5%)、脑膜炎/脑炎73例(0.5%)。调整年龄、性别和大流行时间后,严重神经系统表现与更严重疾病(OR 1.49)、ICU入住(OR 1.45)、ECMO(OR 1.78)、肾脏替代治疗(OR 1.99)及更高的住院、ICU和28天死亡率(OR 1.51、1.37、1.58)相关,且无ICU、无住院和无呼吸机天数更少。入院时脑病常见且与更差结局相关。

要点

  • 16225例住院COVID-19成人中2092例(12.9%)出现严重神经系统表现,入院时脑病最常见(1656例,10.2%)。
  • 卒中331例(2.0%)、癫痫243例(1.5%)、脑膜炎/脑炎73例(0.5%)相对少见,但均与更差结局相关。
  • 调整年龄、性别和大流行时间后,严重神经系统表现与更严重疾病相关(OR 1.49,p<0.001)。
  • 神经系统表现患者更需ICU入住(OR 1.45,p<0.001)、ECMO(OR 1.78,p=0.009)和肾脏替代治疗(OR 1.99,p<0.001)。
  • 神经系统表现患者住院、ICU和28天死亡率更高(OR 1.51、1.37、1.58,p<0.001),无ICU、无住院和无呼吸机天数更少(估计差值-0.84、-1.34、-0.84天,p<0.001)。

适用人群与场景

  • 24个国家179家医院、SCCM Discovery Viral Infection and Respiratory Illness Universal Study COVID-19登记中实验室确诊SARS-CoV-2感染的住院成人。
  • 纳入分析者为登记中16225例具有出院状态数据的患者。

研究设计与关键结果

  • 研究类型:前瞻性观察研究;纳入24个国家179家医院、16225例实验室确诊SARS-CoV-2感染住院成人。
  • 严重神经系统表现总体患病率12.9%(2092/16225);入院时脑病10.2%(1656/16225)、卒中2.0%(331/16225)、癫痫1.5%(243/16225)、脑膜炎/脑炎0.5%(73/16225)。
  • 有严重神经系统表现者年龄更大(中位72岁,IQR 61.0-81.0岁 vs 61岁,IQR 48.0-72.0岁),慢性疾病(包括血管危险因素)患病率更高。
  • 调整年龄、性别和大流行时间后,严重神经系统表现与更严重疾病相关(OR 1.49,p<0.001,以WHO COVID-19 ordinal疾病严重度量表定义)。
  • 神经系统表现患者更可能入住ICU(OR 1.45,p<0.001)和需要重症监护干预:ECMO(OR 1.78,p=0.009)、肾脏替代治疗(OR 1.99,p<0.001)。
  • 神经系统表现患者住院死亡率(OR 1.51,p<0.001)、ICU死亡率(OR 1.37,p<0.001)和28天死亡率(OR 1.58,p<0.001)更高。
  • 神经系统表现患者无ICU天数(估计差值-0.84天,p<0.001)、无住院天数(估计差值-1.34天,p<0.001)和无呼吸机天数(估计差值-0.84天,p<0.001)更少。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,入院时脑病在住院SARS-CoV-2感染患者中常见且与更差结局相关;卒中、癫痫和脑膜炎/脑炎虽较少见,但均与ICU支持利用增加、更严重疾病和更差结局相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To describe the prevalence, associated risk factors, and outcomes of serious neurologic manifestations (encephalopathy, stroke, seizure, and meningitis/encephalitis) among patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

DESIGN: Prospective observational study.

SETTING: One hundred seventy-nine hospitals in 24 countries within the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study COVID-19 Registry.

PATIENTS: Hospitalized adults with laboratory-confirmed SARS-CoV-2 infection.

INTERVENTIONS: None.

RESULTS: Of 16,225 patients enrolled in the registry with hospital discharge status available, 2,092 (12.9%) developed serious neurologic manifestations including 1,656 (10.2%) with encephalopathy at admission, 331 (2.0%) with stroke, 243 (1.5%) with seizure, and 73 (0.5%) with meningitis/encephalitis at admission or during hospitalization. Patients with serious neurologic manifestations of COVID-19 were older with median (interquartile range) age 72 years (61.0-81.0 yr) versus 61 years (48.0-72.0 yr) and had higher prevalence of chronic medical conditions, including vascular risk factors. Adjusting for age, sex, and time since the onset of the pandemic, serious neurologic manifestations were associated with more severe disease (odds ratio [OR], 1.49; p < 0.001) as defined by the World Health Organization ordinal disease severity scale for COVID-19 infection. Patients with neurologic manifestations were more likely to be admitted to the ICU (OR, 1.45; p < 0.001) and require critical care interventions (extracorporeal membrane oxygenation: OR, 1.78; p = 0.009 and renal replacement therapy: OR, 1.99; p < 0.001). Hospital, ICU, and 28-day mortality for patients with neurologic manifestations was higher (OR, 1.51, 1.37, and 1.58; p < 0.001), and patients had fewer ICU-free, hospital-free, and ventilator-free days (estimated difference in days, -0.84, -1.34, and -0.84; p < 0.001).

CONCLUSIONS: Encephalopathy at admission is common in hospitalized patients with SARS-CoV-2 infection and is associated with worse outcomes. While serious neurologic manifestations including stroke, seizure, and meningitis/encephalitis were less common, all were associated with increased ICU support utilization, more severe disease, and worse outcomes.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Cervantes-Arslanian AM, Venkata C, Anand P, et al. Neurologic Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospitalized Patients During the First Year of the COVID-19 Pandemic. Crit Care Explor. 2022. PMID: 35492258. doi:10.1097/CCE.0000000000000686

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。